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Abstract 
Extremely preterm babies are at major risk for adverse neurodevel-
opmental outcome, being the gestational age (GA) the main determi-
nant for a good-quality survival. Aim of this retrospective study was to
investigate the neurodevelopmental outcome in a population of
extremely preterm babies admitted to a single neonatal tertiary care
unit over an 8-year period. All babies born between 23+0 and 25+6
weeks of GA from January 2003 until December 2010 were retrospec-
tively enrolled. Perinatal and neonatal variables were recorded. Motor
and cognitive development was assessed using the neurofunctional
scale (NFS) and the Griffith’s scales at 2 years. Fifty-five out of 122
infants survived to discharge. Survival rates doubled for each addition-
al gestational week from 23 to 25: 16%, 38% and 74% at 23, 24 and 25
weeks GA respectively. Forty-six infants were evaluated at 2 years. A
poor cognitive and motor outcome was observed in all babies born at
23 weeks. Griffith’s general quotient (GQ) was ≥76 in 62% and ≥88 in
33% of babies born between 24 and 25 weeks. No severe motor disabil-
ities were found in 81% of babies born between 24 and 25 weeks.
Preterm premature rupture of membranes, absence of prenatal
steroids, intrauterine growth restriction, male, lower GA and major
brain abnormalities at magnetic resonance imaging (MRI) were sig-
nificantly associated with worse NFS and lower mean GQ at 2 years of
age. GA, gender and abnormal MRI findings remained significantly
associated with impaired NFS at the multivariate analysis. Survival
rates and neurodevelopmental outcome improved with each week of
GA. These results are relevant for clinicians counselling families fac-
ing an unavoidable extremely preterm birth.
Introduction
Preterm birth is a major paediatric public health problem as prema-
turity is associated with a considerable risk to develop cognitive,
behavioral, neurosensory, and motor disabilities. The rates of preterm
birth have risen up in many European countries,1 and a concomitant
successful improvement in survival has been reported through the
years.2 However, a missing reduction in the prevalence of severe dis-
ability still characterizes the extremely prematurely-born population,2
being the gestational age the major discriminant for a good-quality
survival of these extremely preterm babies:2-4 the lower the gestational
age, the higher the risk of death and neurodevelopmental impairment.
Brain development after extremely preterm birth is complex and
poorly understood5 and the outcome in the very early preterm infants
depends on a mixture of well-described haemorrhagic or ischemic
injuries together with less known maturational and trophic distur-
bances affecting the developing brain.6 A range of perinatal factors,
such as mother’s diseases and habits – e.g. nutrition,7 alcohol abuse,8
etc. – infection and inflammation,3,9 fetal growth restriction10,11 as well
as the hospital course and exposure to systemic illness – chronic lung
disease, postnatal infections12-15 – have been shown to further exacer-
bate disturbances in brain maturation with a negative impact on neu-
rodevelopmental outcome.
Recently, the EPICure study reported short term outcomes after
extreme preterm birth (≤26 weeks gestation) in England, comparing
two birth cohorts in 1995 and 2006: a higher survival rate has been
observed.4 Although an overall increase in severe neurological impair-
ment was shown, a bigger proportion of babies born at 24 and 25
weeks’ gestation survived.2
Aim of this retrospective study was to investigate the neurodevelop-
mental outcome and related perinatal risk factors in a population of
extremely preterm babies (23+0 and 25+6 weeks of gestation) admit-
ted to a single neonatal tertiary care unit over an 8-year period.
Materials and Methods
We retrospectively collected data on all extremely preterm babies
with GA at birth between 23+0 to 25+6 admitted to the neonatal terti-
ary care center (intensive care unit) Department of Clinical Sciences
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and Community Health, Fondazione IRCCS Ca’ Granda, Università
degli Studi di Milano, Milan, Italy, over the course of 8 years (since
January 2003 till December 2010). 
Prenatal and perinatal characteristics were recorded: spontaneous
or assisted reproduction, multiple pregnancy, mode of delivery, prenatal
steroids, obstetric complications as gestational hypertension, severe
intrauterine growth restriction (IUGR), preterm premature rupture of
membranes (PPROM), maternal fever >38°C.
The following neonatal variables and main complications during the
neonatal period were collected: gender, GA based on the last menstrual
period and first-trimester ultrasonogram, birth weight, singletons or
twins, Apgar score at 5 minutes, pneumothorax, patent ductus arterio-
sus (PDA) requiring any treatment, bronchopulmonary dysplasia
(BPD) defined as oxygen dependency up to 36 weeks corrected age,
rethinopathy of prematurity (ROP) requiring any treatment, abdominal
surgery, any congenital malformation. 
Infants with birth weight >10th or ≤10th percentile for GA, according
to the North-Italian growth charts, were classified as appropriate for
gestational age (AGA) or small for gestational age (SGA) respectively.16
All babies underwent brain magnetic resonance imaging (MRI) at term
corrected age (TCA). MR images were classified as normal, with minor
abnormalities and severely abnormal (cystic periventricular leukoma-
lacia, arterial or venous stroke, multiple white matter punctate lesions,
post-hemorrhagic ventricular dilatation). Infants were followed-up by
assessments of neurodevelopment at two years of corrected age. The
neurofunctional scale (NFS)17 and the Griffith’s Developmental Scales
II (GMDS II)18 were used. The neurofunctional scale was assigned as
follows: 0, normal function; 1, mild impairment of function (no limita-
tions); 2, moderate impairment of function (possible but limited); 3,
severe impairment of function (possible only with the use of facilita-
tors or assisted devices); 4, function not possible. The Griffith’s scales
consist of six sub-scales (locomotor, personal-social, hearing–speech,
eye-hand coordination, performance and logical scales) which are com-
bined to give the total score, the general quotient (GQ). The Griffith’s
GQ was defined as: normal ≥88, mild cognitive delay between 76 and
87, severe cognitive deficit <76. Severe disability was defined as either
NFS score ≥3 or GQ<76.
Analysis of variance and multivariate analysis were performed to
evaluate the effect of tested factors on outcomes.
Results
One hundred twenty-two infants were born during the study period;
55 babies (45%) survived to discharge but 9 were lost at follow-up.
Twenty-six out of the 46 babies followed-up (56%) were born at 25
weeks’ gestation, 16 (35%) at 24 and 4 (9%) at 23. 
The survival rates according to gestational age are shown in Table 1:
survival rate doubled for each additional gestational week from 23 to 25
but no significant differences were observed between two study periods
(period 1: 2003-2006; period 2: 2007-2010). Prenatal, perinatal and
neonatal variables are shown in Tables 2 and 3.
Forty-six infants were evaluated by both neurofunctional assessment
and Griffith’s scale at 2 years CA; results are reported in Figure 1. The
neurodevelopmental outcome clearly differed according to gestational
age at birth: none of the children born at 23 weeks had a normal neu-
rofunctional or neurobehavioral assessment.
At 2 years of age 34/46 babies (74%) had a NFS score <3, without any
significant change between the 2 study periods (77% in period 1 versus
72% in period 2). Ten to sixteen (62%) babies born at 24 weeks and
24/26 (92%) born at 25 weeks had NFS score <3. A Griffith’s GQ≥76 was
observed in 26/46 (56%) babies: 7/16 (44%) born at 24 and 19/26 (73%)
born at 25 weeks.
Table 1. Survival rate.
                                    2003-2010         2003-2006         2007-2010
                                         (%)                    (%)                   (%)
All weeks                              55/122 (45)              20/46 (43)               35/76 (46)
23 weeks                                 5/32 (16)                 2/16 (13)                 3/16 (19)
24 weeks                                18/47 (38)                6/14 (43)                12/33 (37)
25 weeks                                32/43 (74)               12/16 (75)               20/27 (74)
Table 2. Prenatal and perinatal factors.
                                                                                      N (%)
Assisted reproduction                                                                    9/46 (20)
Gestational hypertension                                                              8/46 (17)
Twins                                                                                                  18/46 (39)
Maternal fever                                                                                  6/46 (13)
PPROM                                                                                              28/46 (61)
Prenatal steroids                                                                            21/46 (46)
IUGR                                                                                                   8/46 (17)
Vaginal delivery                                                                                14/46 (30)
PPROM, preterm premature rupture of membranes; IUGR, intrauterine growth restriction.
Table 3. Neonatal factors.
                                                                                      N (%)
Male                                                                                                   17/46 (37)
SGA                                                                                                     10/46 (21)
BPD                                                                                                    29/46 (63)
Pneumothorax                                                                                  7/46 (15)
Malformation                                                                                     3/46 (6)
PDA any treatment                                                                          31/46 (67)
ROP any treatment                                                                         14/46 (30)
Abdominal surgery                                                                          14/46 (30)
Normal/minor brain MRI abnormalities                                   27/46 (59)
SGA, small for gestational age; BPD, bronchopulmonary dysplasia; PDA, patent ductus arteriosus; ROP,
rethinopathy of prematurity; MRI, magnetic resonance imaging.
Figure 1. Neurofunctional score and Griffith’s general quotient at
2 years of corrected age according to gestational age. Each infant
is represented by a dot. Green dots represent babies with Griffith’s
general quotient≥88, yellow dots a general quotient between 76
and 87, red dots a general quotient<76, black dots stand for
Griffith’s test not performed.
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At the analysis of variance PPROM, absence of prenatal steroids,
IUGR, male, lower GA, and severely abnormal MRI were significantly
associated with higher NFS score (Table 4) and lower mean Griffith’s
GQ (Table 5) at 2 years CA.
At the multivariate analysis gestational age, gender and the pres-
ence of major brain abnormalities remained significantly associated
with severely impaired NFS while no independent factor was identified
for the Griffith’s GQ (Tables 6 and 7). 
Discussion
Our results strongly support the evidence that survival as well as
long-term neurobehavioral outcomes in extremely premature infants
are significantly related to gestational age at birth: the lower the gesta-
tional age, the higher the risk for death or adverse outcome.
The survival rates observed in our population of infants are similar
to those reported by larger studies as the EPICure study4 and almost
double for each additional gestational week from 23 to 25 weeks.
Despite the advances in perinatal care, we did not observe any signifi-
cant improvement over an 8-year period, when two different study peri-
ods were considered.
Neurobehavioral development appears to be mainly related to gesta-
tional age with the most unfavorable outcome occuring in babies born
at 23 weeks’ gestation, at the limit of viability. Griffith’s GQ was ≥76 in
62% and ≥88 in 33% of babies born between 24 and 25 weeks. No
severe motor disabilities were found in 81% of babies born between 24
and 25 weeks.
The poor outcome of babies born at 23 weeks of gestational age was
probably related to the small number of babies, all with unfavorable
conditions at birth (male gender and inadequate prenatal steroid pro-
phylaxis). Caution is needed when comparing results from different
studies on long-term outcome in survivors of extremely preterm birth
as differences in the neonatal management at birth (proactive
approach) profoundly affect survival and rate of disability. 
The occurrence of focal brain lesions plays a pivotal role in determin-
ing child neurodevelopment. Advances in MRI techniques have allowed
an accurate assessment of brain development and gestational age is con-
firmed to be the main determinant of brain vulnerability to different
types of brain lesions. Brain vulnerability is therefore age-dependent and
the concept of gestationally determined brain vulnerability has been
recently emphasized: the site and nature of the injury sustained being
determined by a combination of the characteristics of the insult, the spe-
cific tissue and cell vulnerability and the gestation of the infant at birth.19
However, even in the absence of overt brain lesions, several perina-
tal and postnatal factors have been demonstrated to affect the
microstructure of the developing white and grey matter with a potential
impact on long-term neurodevelopmental outcome. 
In our study IUGR, unlike SGA, was associated with an increased risk
for adverse neurobehavioral outcome although it was not significant at
the multivariate analysis. Intrauterine growth restriction, due to pla-
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Table 4. Effect of prenatal and perinatal factors on outcome at 2
years. P values of one-way ANOVA.
                                                      Griffith’s GQ       NFS score
                                                        (P value)          (P value)
Assisted reproduction                                      0.979                         0.543
Twins                                                                     0.512                         0.535
Gestational hypertension                                0.409                         0.316
Maternal fever                                                    0.676                         0.457
PPROM                                                                 0.388                       0.033*
Prenatal steroids                                              0.013*                      0.011*
IUGR                                                                    0.010*                      0.035*
Vaginal delivery                                                  0.575                         0.335
GQ, general quotient; NFS, neurofunctional scale; PPROM, preterm premature rupture of membranes;
IUGR, intrauterine growth restriction. *P<0.05.
Table 5. Effect of neonatal factors on outcome at 2 years. P values
of one-way ANOVA. 
                                                      Griffith’s GQ       NFS score
                                                        (P value)          (P value)
Male                                                                      0.01                         <0.01
SGA                                                                        0.45                           0.36
GA                                                                         <0.01                        <0.01
Neonatal weight                                                  0.36                           0.85
HC<10° pcl                                                           0.12                           0.68
BPD                                                                        0.07                           0.31
Pneumothorax                                                     0.06                           0.12
Sepsis                                                                    0.99                           0.93
PDA any treatment                                             0.95                            0.7
ROP any treatment                                             0.06                           0.02
Abdominal surgery                                             0.49                            0.5
Severely abnormal brain MRI                         <0.01                        <0.01
GQ, general quotient; NFS, neurofunctional scale; SGA, small for gestational age; GA, gestational age; HC
pcl, head circumference percentile; BPD, bronchopulmonary dysplasia; PDA, patent ductus arteriosus;
ROP, rethinopathy of prematurity; MRI, magnetic resonance imaging.
Table 6. Multivariate analysis for neurofunctional scale at 2 years.
                                                        Variables            P value
NFS score                                                           IUGR                         0.14
                                                                                 GA                          <0.01
                                                                               MRI                         <0.01
                                                                            PPROM                       0.05
                                                                   Prenatal steroids              0.06
                                                                               Male                        <0.01
                                                                    ROP any therapy               0.19
NFS, neurofunctional scale; IUGR, intrauterine growth restriction; GA, gestational age; MRI, magnetic res-
onance imaging; PPROM, preterm premature rupture of membranes; ROP, rethinopathy of prematurity. 
Table 7. Multivariate analysis for Griffith’s general quotient at 2
years.
                                                        Variables            P value
GQ                                                                        Male                          0.42
                                                                              IUGR                          0.3
                                                                   Prenatal steroids              0.06
                                                                               MRI                          0.13
                                                                                 GA                            0.08
GQ, general quotient; IUGR, intrauterine growth restriction; GA, gestational age; MRI, magnetic reso-
nance imaging; PPROM, preterm premature rupture of membranes; ROP, rethinopathy of prematurity.
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cental insufficiency leading to reductions in placental nutrient trans-
fer, hypoxia, and progressive metabolic deterioration in almost any
fetal organ system, has been associated with increased risk of perinatal
mortality and morbidity.20-23 Several follow-up studies have described
neurological impairments and worse neurodevelopmental outcomes in
children born with IUGR.21,24 However, long-term neurological impair-
ment frequently seen in IUGR infants cannot be attributed to the pres-
ence of overt brain lesions. The risk of brain damage in IUGR neonates
could be related to both intrauterine compromised and premature
birth. We recently demonstrated that, although gestational age at birth
is the predominant factor affecting cerebral maturation, IUGR babies
with brain sparing in utero have a mild delay in brain myelination. We
speculated that in our study the lack of statistical association between
IUGR and worse outcome at the multivariate analysis might be related
to the small number of babies.11
PPROM has been reported to be risk factor for unfavorable outcome,
probably due to the underlying physiopathological mechanisms related
to chorioamnionitis;25,26 however, in this study we had no data on pla-
cental histology.
Conclusions
Although this study has several limitations – mainly related to the
small sample size over a quite long period of time – these findings are
relevant for clinicians counselling families facing an unavoidable
extremely preterm birth.
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